alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
HomePolicy Issues…Arms Control and Nonproliferation

Policy Issues

# Arms Control and Nonproliferation

The proliferation of nuclear, chemical, and biological weapons of mass destruction (WMD) and their delivery systems, advanced conventional weapons, and related materials, technologies, and expertise presents a grave threat to the security of the United States and to international peace.

North Korea, for example, pursues nuclear weapons and ballistic missiles in defiance of its international obligations, destabilizing Northeast Asia and increasing the risk of nuclear war. The Iranian regime develops ever more capable ballistic missiles and proliferates them to regional proxies and terrorist forces. Both ISIS and the Assad regime in Syria have used WMD. Russia and China have increasingly potent and diverse WMD and missile arsenals, and they provide advanced arms to partners and proxies in various regions.

It is a strategic goal of the Department of State to counter threats to the United States and the international order. Ultimately, the Department’s work improves the security of the United States and all the nations of the world.

Read more about what specific bureaus are doing to support this policy issue:

**Bureau of Arms Control, Deterrence, and Stability (ADS)**: ADS helps to form key strategies and goals of the U.S. government on arms control. These strategies and goals cover two broad areas: 1) assisting the United States and other nations in negotiating arms control and disarmament treaties and 2) creating strong relationships with other nations to aid in the implementation of treaties. **Read more about ADS.**

**Bureau of International Security and Nonproliferation (ISN):** ISN’s mission is to prevent the spread of WMD, delivery systems, and advanced conventional weapons capabilities and to roll back such proliferation where it has already taken root. ISN tracks, develops, and implements effective responses to proliferation threats and shapes the international security environment to prevent their recurrence. **Read more about ISN**

## 			Top Stories		

					April 4, 2024				

## To Walk the Earth in Safety (2024)

                    -  April 4, 2024							Annual “To Walk the Earth in Safety” (TWEIS) Report						   
                    -  April 4, 2024							Condition (10)(C) Annual Report on Compliance with the Chemical Weapons Convention (CWC)						   
                    -  April 4, 2024							To Walk the Earth in Safety: New Report Showcases U.S. Global Leadership in Conventional Weapons Destruction and Landmine Clearance						   
Read All Top Stories

Back to Top

                        - White House
                        - USA.gov
                        - Office of the Inspector General
                        - Archives
                        - Contact Us

follow us
FacebookTwitterInstagramYouTubeFlickrGovDelivery

                      - Privacy Policy
                      - Accessibility Statement
                      - Copyright Information
                      - FOIA
                      - No FEAR Act

## U.S. Department *of* State

#### The Lessons of 1989: Freedom and Our Future
HomeOffice of the SpokespersonPress Releases...Deputy Secretary Sherman’s Meeting with Omani Deputy Foreign Minister Al Harthy

# 									Deputy Secretary Sherman’s Meeting with Omani Deputy Foreign Minister Al Harthy							

Readout

Office of the Spokesperson

July 27, 2021

The below is attributable to Spokesperson Ned Price:

Deputy Secretary of State Wendy Sherman met today in Muscat with Deputy Foreign Minister Sheikh Khalifa Al Harthy to discuss advancing peace and security in the region and our shared commitment to bolstering the U.S.- Oman bilateral relationship, including advancing new opportunities for trade and investment. The Deputy Secretary also thanked the Deputy Foreign Minister for Oman’s role in mediating peace in the region and underscored the importance of an immediate, comprehensive ceasefire to help bring the war in Yemen to an end.

Tags

Bureau of Near Eastern AffairsDeputy Secretary of StateOffice of the SpokespersonOman

Back to Top
§ 35.8 Safekeeping of money and effects; withdrawals. ( a ) A place for the safekeeping of money and effects of patients shall be provided at each station or hospital, and an itemized receipt therefor shall be furnished to the patient and to any other person who places money or effects therein for the benefit of the patient.
( b ) Money and effects may be withdrawn only by or on behalf of the patient, by his legally appointed representative authorized to receive or dispose of his property (including the money and effects in the custody of the station or hospital), or by a person who is authorized, under the law of the State in which the station or hospital is located, to receive or dispose of the patient's money and effects. In any case in which the officer in charge has had actual notice of the appointment of a legal representative, withdrawals may be made only by such representative or in accordance with his written directions. No delivery shall be made under this paragraph unless ( 1 ) the person receiving the money or effects shall sign an itemized receipt therefor, or
( 2 ) the delivery is witnessed by two persons. The provisions of this paragraph do not prohibit withdrawals made necessary by the provisions of this part for the disposition of money and effects left by patients on death or on departure from the station or hospital, or by the provisions of § 35.10.
```

[Congressional Bills 104th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3337 Introduced in House (IH)]

104th CONGRESS
  2d Session
                                H. R. 3337

To extend certain Medicare community nursing organization demonstration 
                               projects.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             April 25, 1996

 Mr. Ramstad (for himself, Mr. Houghton, Mr. Gutknecht, Mr. Kolbe, Mr. 
 Pastor, Mr. Ewing, Mr. Manton, Mr. Vento, and Mr. Luther) introduced 
  the following bill; which was referred to the Committee on Ways and 
Means, and in addition to the Committee on Commerce, for a period to be 
subsequently determined by the Speaker, in each case for consideration 
  of such provisions as fall within the jurisdiction of the committee 
                               concerned

_______________________________________________________________________

                                 A BILL

 
To extend certain Medicare community nursing organization demonstration 
                               projects.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. EXTENSION OF CERTAIN MEDICARE COMMUNITY NURSING ORGANIZATION 
              DEMONSTRATION PROJECTS

    Notwithstanding any other provision of law, demonstration projects 
conducted under section 4079 of the Omnibus Budget Reconciliation Act 
of 1987 may be conducted for an additional period of 3 years, and the 
deadline for any report required relating to the results of such 
projects shall be not later than 6 months after the end of such 
additional period.
                                 <all>
```
#### Richard P. (Dick) GUIDRY v. Charles William ROBERTS et al.

No. 56830.

Supreme Court of Louisiana.

Sept. 10, 1975.

In re: Joint application by Plaintiff and Defendants for Invocation of Supervisory and/or Original Jurisdiction applying for Invocation of its Plenary Powers Via Supervisory and/or Original Jurisdiction.

Application denied. Applicants have failed to show a compelling reason for this court to bypass the normal procedure in the courts below to resolve the issues presented.
#### BLUE CROSS OF FLORIDA, INC., and Blue Shield of Florida, Inc., Appellants, v. John MARINELLO, Appellee.

No. 73-1105.

District Court of Appeal of Florida, Third District.

April 16, 1974.

PER CURIAM.

Affirmed.
Certification of CEO and CFO Pursuant to
                            18 U.S.C. Section 1350,
                              As Adopted Pursuant to
                 Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of Merisel, Inc. (the "Company") on Form
10-Q for the period ending September 30, 2002 as filed with the Securities and
Exchange Commission on the date hereof (the "Report"), Timothy N. Jenson, as
Chief Executive Officer and Chief Financial Officer of the Company, hereby
certifies, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the
Sarbanes-Oxley Act of 2002, to the best of his knowledge, that:

         (1)      The Report fully complies with the requirements of section 13
(a) of the Securities Exchange Act of 1934; and

         (2) The information contained in the Report fairly presents, in all
material respects, the financial condition and result of operations of the
Company.


/s/Timothy N. Jenson
------------------------------
Timothy N. Jenson
Chief Executive Officer and
  Chief Financial Officer
November 11, 2002


This certification accompanies this Report pursuant to ss.906 of the
Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for
purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
EXHIBIT 31.1





CERTIFICATIONS





I, Robert R. Jones, III, President and Chief Executive Officer (Principal Executive Officer), certify that:





1.             I have reviewed this annual report on Form 10-K of United Bancorporation of Alabama, Inc.;





2.             Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;





3.             Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report;





4.             The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))and have:





(a)      Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the    registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;





(b)      Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this annual report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this annual report based on such evaluation; and





(c)      Disclosed in this annual report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and





5.             The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):





(a)      All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and





(b)      Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.








Date:       March 29, 2011








/s/ Robert R. Jones, III
 Robert R. Jones, III


President and Chief Executive Officer


(Principal Executive Officer)
HomeOffice of the SpokespersonPress Releases...Fulbright Foreign Scholarship Board Elects New Chair, Vice Chair

# 									Fulbright Foreign Scholarship Board Elects New Chair, Vice Chair							

Media Note

Office of the Spokesperson

December 7, 2022

The U.S. Department of State announced yesterday that the Fulbright Foreign Scholarship Board (FFSB) held its annual leadership elections today and elected Donna Brazile as the Board Chair and Michael Trager as Vice Chair.

The 12-Member Fulbright Foreign Scholarship Board was established by Congress to supervise the global Fulbright Program as authorized by the Mutual Educational and Cultural Exchange Act of 1961 (PL87-256), also called the Fulbright-Hays Act.

Appointed by the President of the United States and representing diverse facets of American society, the Board selects students, scholars, teachers, and professionals from the United States and abroad to participate in Fulbright exchanges.

In close coordination with the U.S. Department of State’s Bureau of Educational and Cultural Affairs, U.S. embassies, bilateral Fulbright Commissions in partner countries, and the U.S. Department of Education’s International and Foreign Language Office of Postsecondary Education, the Board promotes the Fulbright Program to audiences around the world. The Board meets quarterly to establish policies for Fulbright participant selection and Program operations.

For more information on the Board and Fulbright, please visit eca.state.gov/fulbright.

Tags

Bureau of Educational and Cultural AffairsElectionsFulbright ProgramOffice of the Spokesperson

Back to Top
HomeOffice of the SpokespersonPress Releases...G7 Foreign Ministers’ Statement on the Situation in Burma

# 									G7 Foreign Ministers’ Statement on the Situation in Burma							

Media Note

Office of the Spokesperson

February 3, 2021

*The text of the following statement was released by the G7 foreign ministers of Canada, France, Germany, Italy, Japan, the United Kingdom and the United States of America and the High Representative of the European Union.*

*Begin Text:*

We, the G7 Foreign Ministers of Canada, France, Germany, Italy, Japan, the United Kingdom and the United States of America and the High Representative of the European Union, are united in condemning the coup in Myanmar.

We are deeply concerned by the detention of political leaders and civil society activists, including State Counsellor Aung San Suu Kyi and President Win Myint, and targeting of the media. We call upon the military to immediately end the state of emergency, restore power to the democratically elected government, to release all those unjustly detained and to respect human rights and the rule of law. The November election results must be respected and Parliament should be convened at the earliest opportunity.

The military’s restrictions on information flows are deeply concerning. Civilians, including civil society and the media, must not be subject to reprisals in any form. We also call for unrestricted humanitarian access to support the most vulnerable.

G7 Foreign Ministers recall their 2019 communique in which we restated our commitment to Myanmar’s democratic transition, peace and accountability for human rights violations and abuses.

We stand with the people of Myanmar who want to see a democratic future.

*End text.*

Tags

Bureau of Democracy, Human Rights, and LaborBureau of East Asian and Pacific AffairsBureau of European and Eurasian AffairsBureau of Western Hemisphere AffairsBurmaCanadaDemocracyFranceGermanyItalyJapanOffice of the SpokespersonUnited Kingdom

Back to Top
EXHIBIT 32.1



CERTIFICATION PURSUANT TO

18 U.S.C.
SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Annual Report of RegeneRx (the Company) on Form 10-KSB for the year ending December 31, 2004 as filed with the Securities and Exchange Commission on the date hereof (the Annual
Report), I, J.J. Finkelstein, President and Chief Executive Officer of RegeneRx, certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



| | (1) | The Annual Report fully complies with the requirements of the Securities Act of 1933; and
| | --- | -----------------------------------------------------------------------------------------



| | (2) | The information contained in the Annual Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------------



|               |  |  |  |                                                                                                                     
|-------------- |  |  |  | --------------------------------------------------------------------------------------------------------------------
|               |  | 
|March 31, 2005 |  |  |  | /s/ J.J. Finkelstein                                                                                                
|               |  |  |  | J.J. Finkelstein President and Chief Executive
Officer (Principal Executive Officer and Principal Financial Officer)
EXHIBIT
32.2





SECTION
906 – CERTIFICATION OF CHIEF FINANCIAL OFFICER





Certification
of Chief Financial Officer


Pursuant
to 18 U.S.C. § 1350


(Section
906 of the Sarbanes-Oxley Act of 2002)








In connection with the Annual Report on
Form 10-K for the year ended December 31, 2007, of Britton & Koontz Capital
Corporation (the “Company”), as filed with the Securities Exchange Commission on
the date hereof (the “Annual Report”), I, William M. Salters, Chief Financial
Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:







(1)
            the
      Annual Report fully complies with the requirements of Section 13(a) or
      15(d) of the Securities Exchange Act of 1934, as amended;
    and





(2)
            the
      information contained in the Annual Report fairly presents, in all
      material respects, the financial condition and results of operations of
      the Company.




















Date:
March 11,
2008                                                                           /s/ William M.
Salters


William M. Salters


Chief Financial Officer
# C_2005196EN.01000402.xml

| 11.8.2005 | EN | Official Journal of the European Union | C 196/4 |
| --- | --- | --- | --- |

11.8.2005

EN

Official Journal of the European Union

C 196/4

---

Non-opposition to a notified concentration

(Case COMP/M.3857 — SITA/Flughafen Düsseldorf/FDITG)

(2005/C 196/07)

(Text with EEA relevance)

On 29 July 2005, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | from the Europa competition web site (http://europa.eu.int/comm/competition/mergers/cases/). This web site provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

from the Europa competition web site (http://europa.eu.int/comm/competition/mergers/cases/). This web site provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website under document number 32005M3857. EUR-Lex is the on-line access to European law. (http://europa.eu.int/eur-lex/lex) |
| --- | --- |

—

in electronic form on the EUR-Lex website under document number 32005M3857. EUR-Lex is the on-line access to European law. (http://europa.eu.int/eur-lex/lex)

---
§ 417.808 Interim per capita payments. The HCPP follows the principles specified in §§ 417.570 and 417.572 on interim per capita payments, except for the following: ( a ) When applying these principles to HCPPs, the term “reporting period” should be used instead of the term “contract period” contained in that section.
( b ) An HCPP must submit to CMS an annual operating budget and enrollment forecast, in the form and detail specified by CMS, at least 60 days before the beginning of each reporting period. A reporting period must be 12 consecutive months, except that the HCPP's initial reporting period for participating in Medicare may be as short as 6 months or as long as 18 months.
( c ) An HCPP must submit to CMS an interim cost report and enrollment data applicable to the first 6-month period of the HCPP's reporting period in the form and detail specified by CMS. The interim cost report must be submitted not later than 45 days after the close of the first 6-month period of the HCPP's reporting period.
( d ) In lieu of an interim payment based on the actual monthly enrollment in an HCPP, CMS and the HCPP may agree to a uniform monthly interim reimbursement rate for a reporting period. This interim rate is based on the HCPP's budget and enrollment forecast, if CMS is satisfied that the rate is consistent with efficiency and economy, and will not result in excessive adjustment at the end of the reporting period.
file:///P|/Steam/Sampling/Plant%20Selection/Questions%20for%20Plants/Final%20Versions/Big%20Bend/New%20Text%20Document.txt[1/21/2010 10:08:28 AM]

>>> "Young, Kevin A." <kayoung@tecoenergy.com> 12/11/2009 4:55 PM >>>

Kurtis,

Please find attached Tampa Electric Company's (TEC) response to the follow up questions on Big Bend's FGD 

wastewater treatment system. Please contact me if you have any questions.

Thanks,

Kevin

? Please consider the environmental impact before printing this e-mail

-----Original Message-----

From: Kurtis Blohm [mailto:Kurtis.Blohm@erg.com] 

Sent: Monday, December 07, 2009 12:38 PM

To: Young, Kevin A.

Cc: Hall.Josh@epamail.epa.gov; Jordan.Ronald@epamail.epa.gov; Deborah Bartram; Thomas Finseth

Subject: Follow Up Questions on Big Bend's FGD Wastewater Treatment System

Kevin,

Thank you for answering my questions regarding the Big Bend plant last week. As we discussed during the call, EPA 

would like to confirm the operation of the FGD systems and FGD wastewater treatment systems at Big Bend. This upto-date information will be used by EPA to make decisions about which plants and systems to select for the sampling 

episodes as part of the rulemaking.

I am attaching a list of follow-up questions from our call.

We would appreciate receiving responses to these questions by Friday, December 11th. As noted in the questions, 

please identify if any information should be handled as confidential business information. Please let me know if you 

have any questions. Additionally, you can contact Josh Hall via e-mail (hall.josh@epa.gov) or by phone (202-566-

1002) if you have any questions.

Thanks for your time,

Kurt

Kurt Blohm

Chemical Engineer

Eastern Research Group, Inc.

14555 Avion Pkwy, Suite 200

Chantilly, VA 20151

(703) 633-1675
#### WOMETCO ENTERPRISES, INC., a Florida Corporation, Petitioner, v. BUGGY BUS, INC., a Florida Corporation, Respondent.

No. 46067.

Supreme Court of Florida.

Dec. 5, 1974.

Certiorari denied. 296 So.2d 606.

ADKINS, C. J., and ROBERTS, Me-CAIN, DEKLE and OVERTON, JJ., concur.